Table of Contents
Table of Contents
Preface
Chapter 1. Clinical Manifestations of Cystic Fibrosis and Their Management
Ibrahim A. Janahi and Abdul Rehman (Professor of Clinical Pediatrics, Weill-Cornell Medical College–Qatar, and others)
Chapter 2. Liver Disease in Cystic Fibrosis: Prevalence, Risk Factors, and Outcomes
Fustik Stojka (Center for Cystic Fibrosis, University Children’s Clinic, Skopje, R. Macedonia)
Chapter 3. Lung Transplantation for Cystic Fibrosis
Zubin Mukadam, Mehgan Holland and Keith C. Meyer (Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, and others)
Chapter 4. New Cystic Fibrosis Therapy
Sabrine Oueslati (Biochemistry Laboratory, Children’s Hospital; Research laboratory, “Haemoglobinopathies and Cystic fibrosis, LR00SP03”, Tunis, Tunisia)
Chapter 5. Distinct Patterns of Pulmonary Injury and Fibrosis Induced by Intratracheal and Subcutaneous Bleomycin in the Mouse: Relevance for Distinct Forms of Human Lung Fibrosis
Anna P. Lam, Erica L. Herzog, Denisa Melichian, Joseph Sennello, Ye Gan, Kirtee Raparia, Robert Homer, Anjana Yeldandi, and John Varga (Divisions of Rheumatology, Pulmonary and Critical Care Medicine and Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA, and others)
Chapter 6. Sleep Disorders in Idiopathic Pulmonary Fibrosis
Hans Schweisfurth (Institute for Pulmonary Research (IPR), Cottbus, Germany)
Chapter 7. N-acetylcysteine therapy in Idiopathic Pulmonary Fibrosis
E. Rindone, L. Rosset and C. Carnuccio (Division of respiratory disease, Department of Clinical Biological Sciences, Faculty of Medicine and Surgery, San Luigi Gonzaga, University of Turin, Turin, Italy, and others)
Index
